Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type - Place of the extracellular glutathione peroxidase

Free Radical Biology and Medicine

Volumn 20, Issue 4, 1996, Pages 579-587

  Ceballos Picot, Irène ^a   Merad Boudia, Mansouria ^a   Nicole, Annie ^a   Thevenin, Marc ^a   Hellier, Georgette ^b   Legrain, Sylvie ^c   Berr, Claudine ^b,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Age; Alzheimer's disease; Free radicals; Glutathione peroxidase; Oxidative stress; Peripheral markers; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE PEROXIDASE; SELENIUM; SUPEROXIDE DISMUTASE;

AGING; ALZHEIMER DISEASE; CELL DAMAGE; COGNITIVE DEFECT; DEMENTIA; DETOXIFICATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SENILE PLAQUE;

EID: 0029871412     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(95)02058-6     Document Type: Article

References (45)

1. Ceballos, I.; Agid, F.; Delacourte, A.; Defossez, A.; Nicole A.; Sinet, P. M. Parkinson's disease and Alzheimer's disease: Neurodegenerative disorders due to brain antioxidant system deficiencies? In: Emerit, I.; Packer, L.; Auclair, C., eds. Advances in experimental biology and medicine. Antioxidant in therapy and preventive medecine. New York: Plenum Press; 1990:493-498.
2. Volicer, L.; Crino, P. B. Involvement of free radicals in dementia of the Alzheimer's type: A hypothesis. Neurobiol. Aging 11:567-571; 1990.
3. Hensley, K.; Carney, J. M.; Mattson, M. P.; Aksenova, M.; Harris, M.; Wu, J. F.; Floyd, R. A.; Butterfield, D. A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91:3270-3274; 1994.
4. Dyrks, T.; Weideman, A.; Multhaup, G.; Salbaum, J. M.; Lemaire, H. K.; Kang, J.; Müller-Hill, B.; Masters, C. L.; Beyreuther, K. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J. 7:949-957; 1988.
5. Blass, J. P.; Baker, A. C.; Ko, L. W.; Black, R. S. Expression of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47:864-869; 1990.
6. Sinet, P. M.; Ceballos-Picot, I. Role of free radicals in Alzheimer's disease and Down's syndrome. In: Packer, L.; Prilipko, L; Christen, Y., eds. Free radicals in the brain. New York: Springer Verlag; 1992:91-98.
7. Subbarao, K. V.; Richarson, J. S.; Ang L. C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55:342-345; 1990.
8. Palmer, A. M.; Burns, M. A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:338-342; 1994.
9. Smith, C. D.; Carney J. M.; Starke-Reed, P. E.; Oliver, C. N.; Stadtman, E. R.; Floyd, R. A.; Markesbery, W. R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88:10540-10543; 1991.
10. Crapper-McLachlan, D. R.; Dalton, D. R.; Kruck, T. P. A.; Bell, M. Y.; Smith, W. L.; Kalow, W.; Andrews, D. F. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337:1304-1308; 1991.
11. Halliwell, B. Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Radic. Biol. Med. 7:645-651; 1989.
12. Ceballos-Picot, I.; Nicole, A.; Briand, P.; Grimber, G.; Delacourte, A.; Desfossez, A.; Javoy-Agid, F.; Lafon, M.; Sinet, P. M. Neuronal-specific-expression of copper-zinc superoxide dismutase gene in transgenic mice. Brain Res. 552:198-214; 1991.
13. Ceballos-Picot, I.; Nicole, A.; Clement, J. M.; Bourre, J. M.; Sinet, P. M. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutat. Res. 275:281-293; 1992.
14. Przedborki, S.; Jackson-Lewis, V.; Kostic, V.; Carlson, E.; Epstein, C. J.; Cadet, J. L. Superoxide dismutase, catalase and glutathione peroxidase in copper-zinc superoxide dismutase transgenic mice. J. Neurochem. 58:1760-1767; 1992.
15. Marklund, S. L.; Adolfsson, R.; Gottfries, C. G.; Winblad, B. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J. Neurol. Sci. 67:319-325; 1985.
16. Delacourte, A.; Defossez, A.; Ceballos, I.; Nicole, A.; Sinet, P. M. Preferential expression of copper-zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease. Neurosci. Lett. 92:247-253; 1988.
17. Ceballos, I.; Javoy-Agid, F.; Hirsch, E. C.; Dumas, S.; Kamoun, P.; Sinet, P. M.; Agid, Y. Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization. Neurosci. Lett. 105:41-46; 1989.
18. Diagnostic and statistical manual of mental disorders. 3rd ed revised. Washington, DC: American Psychiatric Association; 1987.
19. Tsuchihashi, M. Zur Kenntnis des blutkatalase. Biochem. Z. 140:63-112; 1923.
20. Ceballos-Picot, I.; Trivier, J. M., Nicole, A.; Thevenin, M. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin. Chem. 38:66-70; 1992.
21. Marklund, S.; Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47:469-474; 1974.
22. Carmagnol, F.; Sinet, P. M.; Jerome, H. Selenium-dependent and non-selenium dependent glutathione peroxidases in human tissue extracts. Biochim. Biophys. Acta 759:49-57; 1983.
23. Calberg, I.; Mannervick, B. Glutathione reductase. Methods Enzymol. 113:484-490; 1985.
24. Berr, C.; Nicole, A.; Godin, J.; Ceballos-Picot, I.; Thevenin, M.; Dartigues, J. F.; Alperovictch, A. Selenium and oxygen metabolizing enzymes in elderly community residents: A pilot epidemiological study. J. Am. Geriatr. Soc. 41:143-148; 1993.
25. Harman, D. The aging process. Proc. Natl. Acad. Sci. USA 78:7124-7128; 1981.
26. Sulkawa, R.; Nordberg, U. R.; Erkinjuntti, T.; Westermack, T. Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer's disease and other dementia. Acta Neurol. Scand. 73:487-489; 1986.
27. Jeandel, C.; Nicolas, M. B.; Dubois, F.; Nabet-Belleville F.; Penin, F.; Cuny, G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35:275-282; 1989.
28. Zubenko, G. S.; Sauer, P. SOD-1 activity and platelet membrane fluidity in Alzheimer's disease. Biol. Psychiatry 25:671-678; 1989.
29. de Lustig, E.; Serra, J. A.; Kohan, S.; Canziani, G. A.; Famulari, A. L.; Dominguez, R. A. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients. J. Neural. Sci. 115:18-25; 1989.
30. Serra, J. A.; Famulari, A. L.; Kohan, S.; Marschoff, E. R.; Dominguez, R. O.; de Lustig, E. Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patient and their first-degree relatives. J. Neurol. Sci. 122:179-188; 1994.
31. Percy, M. E.; Dalton, A. J.; Markovic, V. D. Red cell superoxide dismutase, glutathione peroxidase and ctalase in Down syndrome patients with and without manifestations of Alzheimer disease. Am. J. Med. Genet. 35:459-467; 1990.
32. Perrin, R.; Briancon, S.; Jeandel, C. Blood activity of CuZn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease. A case-control study. Gerontology 36: 306-313; 1990.
33. Fernandes, M. A. S.; Santana, I.; Januario, C.; Cunha, L.; Oliveira, C. R. Decreased superoxide dismutase activity in erythrocytes from patients with Alzheimer's disease. Med. Sci. Res. 21:679-682; 1993.
34. Anneren, G.; Gardner, A.; Lundin, T. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of the Alzheimer type. Acta Neurol. Scand. 73:586-589; 1986.
35. Basun, H.; Forssell, L. G.; Wetterberg, L. Windblad. Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and in Alzheiemr's disease. J. Neural. Transm. 4:231-258; 1991.
36. Evans, P. H.; Klinowski, J.; Yano, E.; Urano, N. Alzheimer's disease: A pathogenic role for aluminosilicate-induced phagocytic free radicals. Free Radic. Res. Commun. 6:317-321; 1989.
37. Zubenko, G. S.; Cohen, B. M.; Boller, F.; Reynolds, C. F.; Malinakova, I.; Keefe, N.; Chojnacki, B. Platelet membrane abnormality in Alzheimer's disease. Ann. Neurol. 22:237-244; 1987.
38. Avissar, N.; Ornt, D. B.; Yagil, Y.; Horowitz, S.; Watkins, R. H.; Kerl, E. A.; Takahashi, K.; Palmer, I. S.; Cohen, H. J. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol. 266:C367-375; 1994.
39. Amstad, P.; Moret, R.; Cerutti, P. Glutathione peroxidase compensates for the hypersensitivity of CuZn-superoxide dismutase overproduces to oxidant stress. J. Biol. Chem. 269:1606-1609; 1994.
40. Ceballos, I.; Delabar, J. M.; Nicole, A.; Kamoun, P. Sinet, P. M. Expression of transfected human CuZnSOD in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochim. Biophys. Acta 949:58-64; 1988.
41. Toussaint, O.; Houbion, A.; Remacle, J. Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity. Toxicology 81:89-101; 1993.
42. Behl, C.; Davis, J. B.; Lesley, R.; Schubert, D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827; 1994.
43. Bunker, V. W.; Lawson, M. S.; Stansfield, M. F.; Clayton, B. E. Selenium balance studies in apparently healthy and housebound elderly people eating self-selected diets. Br. J. Nutr. 59:171-180; 1988.
44. Lloyd, B.; Lloyd, R. S.; Clayton, B. E. Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J. Epidemiol. Coll. Health 37:213-217; 1983.
45. Neve, J. Physiological and nutritionnal importance of selenium. Experientia 47:187-193; 1991.